The results of the high secretion of AnxA2 from TNBC cell lines were further confirmed the conclusion derived from the serum samples of the breast cancer patients in this study, which suggest that high secretion of AnxA2 is specifically associated with the triple-negative subtypes of breast cancer patients. Here, ANXA2 is linked to breast cancer.